商業用フローリングの世界市場分析:製品別(ソフトカバー、弾力性、非弾力性、シームレス、木材・ラミネート)、用途別、地域別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Commercial Flooring Market Analysis By Product (Soft Coverings, Resilient, Non-resilient, Seamless, Wood & Laminates), By Application, By Region, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Infection Control Market – SWOT Analysis, by Factor (Political & legal, economic and technological)
3.6 Industry Analysis – Porter’s Five Forces Model
Chapter 4 Infection Control Market: Type Estimates & Trend Analysis
4.1 Infection Control Market: Type Movement Analysis
4.2 Equipment
4.2.1 Equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.2 Disinfectors
4.2.2.1 Disinfectors market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.2.2 Washers
4.2.2.2.1 Washers market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.2.3 Flushers
4.2.2.3.1 Flushers market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.2.4 Endoscope reprocessors
4.2.2.4.1 Endoscope reprocessors market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.3 Sterilization equipment
4.2.3.1 Sterilization equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.3.2 Heat sterilization equipment
4.2.3.2.1 Heat sterilization equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.3.3 Low temperature equipment
4.2.3.3.1 Low temperature equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.3.4 Radiation sterilization equipment
4.2.3.4.1 Radiation sterilization equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.3.5 Filtration sterilization equipment
4.2.3.5.1 Filtration sterilization equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.2.3.6 Liquid sterilization equipment
4.2.3.6.1 Liquid sterilization equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3 Services
4.3.1 Services market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3.2 Contract sterilization
4.3.2.1 Contract sterilization market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3.2.2 Ethylene oxide sterilization
4.3.2.2.1 Ethylene oxide sterilization market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3.2.3 E-beam sterilization
4.3.2.3.1 E-beam sterilization market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3.2.4 Gamma sterilization
4.3.2.4.1 Gamma sterilization market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3.2.5 Others
4.3.2.5.1 Others market estimates and forecasts, 2014 – 2025 (USD Billion)
4.3.3 Waste disposal
4.3.3.1 Waste disposal market estimates and forecasts, 2014 – 2025 (USD Billion)
4.4 Consumables
4.4.1 Consumables market estimates and forecasts, 2014 – 2025 (USD Billion)
4.4.2 Waste disposal
4.4.2.1 Waste disposal market estimates and forecasts, 2014 – 2025 (USD Billion)
4.4.3 Disinfectants
4.4.3.1 Disinfectants market estimates and forecasts, 2014 – 2025 (USD Billion)
4.4.4 Sterilization supplies
4.4.4.1 Sterilization supplies market estimates and forecasts, 2014 – 2025 (USD Billion)
4.4.5 Personal protective equipment
4.4.5.1 Personal protective equipment market estimates and forecasts, 2014 – 2025 (USD Billion)
4.4.6 Others
4.4.6.1 Others market estimates and forecasts, 2014 – 2025 (USD Billion)
Chapter 5 Infection Control Market: End-use Estimates & Trend Analysis
5.1 Infection Control Market: End-use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market estimates and forecasts, 2014 – 2025 (USD Billion)
5.3 Medical Device Companies
5.3.1 Medical device companies market estimates and forecasts, 2014 – 2025 (USD Billion)
5.4 Clinical Laboratories
5.4.1 Clinical laboratories market estimates and forecasts, 2014 – 2025 (USD Billion)
5.5 Pharmaceutical Companies
5.5.1 Pharmaceutical companies market estimates and forecasts, 2014 – 2025 (USD Billion)
5.6 Others
5.6.1 Others market estimates and forecasts, 2014 – 2025 (USD Billion)
Chapter 6 Infection Control Market: Regional Estimates & Trend Analysis, by Type & End-Use
6.1 Infection Control Market Shares by Region, 2016 & 2025
6.2 North America
6.2.1 North America infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.2.2 North America infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.2.3 U.S.
6.2.3.1 U.S. infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.2.3.2 U.S. infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.2.4 Canada
6.2.4.1 Canada infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.2.4.2 Canada infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.3 Europe
6.3.1 Europe infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.3.2 Europe infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.3.3.2 Germany infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.3.4 UK
6.3.4.1 UK infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.3.4.2 UK infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.4.2 Asia Pacific infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.4.3 Japan
6.4.3.1 Japan infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.4.3.2 Japan infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.4.4 China
6.4.4.1 China infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.4.4.2 China infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.4.5 India
6.4.5.1 India infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.4.5.2 India infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.5.2 Latin America infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.5.3 Brazil
6.5.3.1 Brazil infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.5.3.2 Brazil infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.5.4 Mexico
6.5.4.1 Mexico infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.5.4.2 Mexico infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.6 MEA
6.6.1 MEA infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.6.2 MEA infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
6.6.2.1 MEA infection control market estimates and forecasts, 2014 – 2025 (USD Billion)
6.6.3 South Africa
6.6.3.1 South Africa infection control market estimates and forecasts, by type, 2014 – 2025 (USD Billion)
6.6.3.2 South Africa infection control market estimates and forecasts, by end-use, 2014 – 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 3M Company
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Belimed AG
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Halyard Health, Inc.
7.3.3.1 Company overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Getinge Group
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Advanced Sterilization Products
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Matchana Group
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Sterigenics International
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic initiatives
7.3.8 MMM Group
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Cantel Medical Corporation
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic initiatives
7.3.10 STERUS Corporation
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives
Chapter 8. Company Profiles
8.1. Amtico
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. The Armstrong Flooring, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Changzhou Liberty Diseno New Material Co., Ltd. (CNBM)
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Congoleum
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Flowcrete (RPM)
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Forbo International SA
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Gerflor
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Hanwha
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Interface Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. IVC Group
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. James Halstead Plc.
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. LG Hausys
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Mannington Mills Inc.
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
8.14. Milliken
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives
8.15. Mohawk Industries
8.15.1. Company Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Strategic Initiatives
8.16. Nora Systems
8.16.1. Company Overview
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Strategic Initiatives
8.17. Novalis
8.17.1. Company Overview
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Strategic Initiatives
8.18. NOX Corporation
8.18.1. Company Overview
8.18.2. Financial Performance
8.18.3. Product Benchmarking
8.18.4. Strategic Initiatives
8.19. Pergo
8.19.1. Company Overview
8.19.2. Financial Performance
8.19.3. Product Benchmarking
8.19.4. Strategic Initiatives
8.20. Polyflor Ltd.
8.20.1. Company Overview
8.20.2. Financial Performance
8.20.3. Product Benchmarking
8.20.4. Strategic Initiatives
8.21. Shanghai Da Julong New Material Co. Ltd
8.21.1. Company Overview
8.21.2. Financial Performance
8.21.3. Product Benchmarking
8.21.4. Strategic Initiatives
8.22. Shaw Industries Group, Inc.,
8.22.1. Company Overview
8.22.2. Financial Performance
8.22.3. Product Benchmarking
8.22.4. Strategic Initiatives
8.23. TAJ Flooring, Inc.
8.23.1. Company Overview
8.23.2. Financial Performance
8.23.3. Product Benchmarking
8.23.4. Strategic Initiatives
8.24. TKflor
8.24.1. Company Overview
8.24.2. Financial Performance
8.24.3. Product Benchmarking
8.24.4. Strategic Initiatives
8.25. TOLI Corporation
8.25.1. Company Overview
8.25.2. Financial Performance
8.25.3. Product Benchmarking
8.25.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:商業用フローリングの世界市場分析:製品別(ソフトカバー、弾力性、非弾力性、シームレス、木材・ラミネート)、用途別、地域別、セグメント予測、2014-2025
■ 英文:Commercial Flooring Market Analysis By Product (Soft Coverings, Resilient, Non-resilient, Seamless, Wood & Laminates), By Application, By Region, And Segment Forecasts, 2014-2025
■ 発行日:2017年5月10日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707203
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。